Alexander Light

@AJWLight

NIHR Doctoral Fellow @IP_London @NIHRresearch | Urology registrar @NorthLonUrol | @Packers owner | 🇬🇧🇲🇾🇨🇳

London, England imperial.ac.uk/people/a.light Joined December 2017

3K Following 2.1K Followers 2.9K Posts

Latest posts 5

Pinned post

Alexander Light @AJWLight Jul 17

A career highlight to lead this study on 10 year outcomes in almost 3500 men undergoing focal therapy, now published in @EUplatinum

And fantastic to see the widespread UK media coverage today across TV, radio, and print!

Many thanks to my collaborators and mentors 🙏

Imperial Prostate @IP_London Jul 17

🚨 NEW IN @EUplatinum! 🚨

The largest analysis of focal therapy by Imperial Prostate and UK colleagues, reporting 1⃣0⃣-year outcomes after focal HIFU and cryotherapy in 3⃣4⃣7⃣7⃣ men 🔥🧊

Led by @AJWLight @LondonProstate1 @TaimurShah

Read for free: europeanurology.com/article/S0302-…

View quoted post on X

Alexander Light @AJWLight Sep 18

Interesting

TARGET international consensus guidance - we had uncertainty as to whether the pre-treatment MRI needs DCE (Eur Urol 2024; europeanurology.com/article/S0302-…)

But PI-FAB, published by the same institution as PRIME, requires comparison with the pre-treatment DCE images 🤷

www.europeanurology.com The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging... Magnetic resonance imaging (MRI) can detect disease recurrence after focal therapy for prostate cancer, but there is no robust guidance regarding its use. The TARGET consensus recommendations provide...

Wei Phin Tan, MD, MHS, FACS Verified account @DrTanWP Sep 17

Great point-counterpoint at the podium today: @veerukasi arguing biparametric MRI should be the new standard of care for prostate cancer diagnosis vs @RaisBahrami making the case to keep contrast. PRIME (JAMA 2025) says bpMRI is noninferior to mpMRI for csPCa (29.0% vs 29.6%, 555 men, 22 centers). Shorter scan, no gadolinium. The counterargument: DCE still helps with equivocal PI-RADS 3 lesions and better defines lesion size, which matters for focal therapy planning. Where do you land? @FocalSociety @Endo_Society #ProstateCancer #bpMRI #PRIMEtrial #FTS2026 @JAMA_current

View quoted post on X

Alexander Light @AJWLight Aug 28

Wholeheartedly recommend applying!!

Imperial Prostate @IP_London Aug 28

📣 Calling all aspiring academic urologists: we are hiring!

Applications open soon for the 2027 @NIHRresearch Academic Clinical Fellowship in urology.

Join our 🌍-leading #ProstateCancer research group led by @LondonProstate1 💫

imperial.ac.uk/medicine/study…
View quoted post on X

Alexander Light @AJWLight Jul 30

Fantastic trial that will provide definitive evidence for bpMRI vs mpMRI, and fusion versus cognitive biopsy!

Imperial Prostate @IP_London Jul 30

#IP7 #PACIFIC has recruited its 2️⃣0️⃣0️⃣0️⃣th patient! Well done to all sites involved, and to Southend @MSEHospitals who recruited patient number 2000!

Not long to go!

View quoted post on X

Alexander Light @AJWLight Jul 18

Fantastic to see our study covered in page 2 of @thetimes newspaper today!